Experimental Cell Therapy Improves Skin Resilience, Advancing Treatments for Skin Injuries
November 10, 2026
November 10, 2026
BALTIMORE, Maryland, Nov. 10 -- Johns Hopkins Medicine posted the following news release:
* * *
Experimental Cell Therapy Improves Skin Resilience, Advancing Treatments for Skin Injuries
*
In a phase I clinical trial funded by the National Institutes of Health and the Maryland Stem Cell Research Fund, Johns Hopkins Medicine researchers say they have partially transformed ordinary human skin cells into volar skin -- the durable skin found exclus . . .
* * *
Experimental Cell Therapy Improves Skin Resilience, Advancing Treatments for Skin Injuries
*
In a phase I clinical trial funded by the National Institutes of Health and the Maryland Stem Cell Research Fund, Johns Hopkins Medicine researchers say they have partially transformed ordinary human skin cells into volar skin -- the durable skin found exclus . . .